Search

Your search keyword '"Ballman, Karla V."' showing total 1,005 results

Search Constraints

Start Over You searched for: Author "Ballman, Karla V." Remove constraint Author: "Ballman, Karla V."
1,005 results on '"Ballman, Karla V."'

Search Results

151. PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

152. Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population

158. Ischemic stroke after heart failure: a community-based study

159. Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly

160. SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

163. VALIDATION OF A GENOMIC CLASSIFIER THAT PREDICTS METASTATIC DISEASE PROGRESSION IN MEN WITH HIGH RISK PATHOLOGICAL FEATURES POST-PROSTATECTOMY: 2130

164. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation

168. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

169. Efficacy of osimertinib against EGFRvIII+ glioblastoma

170. ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.

171. Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration-resistant prostate cancer (mCRPC).

172. PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

174. Role of Specialized Composition of SWI/SNF Complexes in Prostate Cancer Lineage Plasticity

175. Dose-escalation results of a phase I study of 225Ac-J591 for progressive metastatic castration resistant prostate cancer (mCRPC).

176. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort

177. Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

178. Clinical features of neuroendocrine prostate cancer

182. A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-Versus-Host Disease in Haplo-Cord Transplantation, As a Potential Alternative to Anti-Thymocyte Globulin

189. Phase III Trial of Carmustine and Cisplatin Compared With Carmustine Alone and Standard Radiation Therapy or Accelerated Radiation Therapy in Patients With Glioblastoma Multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials

Catalog

Books, media, physical & digital resources